Sukhani not upbeat on Glenmark Pharma

Sudarshan Sukhani of s2analytics.com is not upbeat on Glenmark Pharma.

Sukhani told CNBC-TV18, “KPIT Cummins has moved well. It had a very big day. It’s consolidated for a couple of days and then continued its run. I think it’s a buy that can be taken even today after the big gains it has seen. I am not so upbeat on Glenmark for two reasons. First, it’s quite possible that it has come and touched the resistance level in spite of the gains. Second, there are other options Cipla, Ranbaxy which are more interesting.”